AI-generated analysis. Always verify with the original filing.
Apimeds Pharmaceuticals US, Inc. disclosed that a Stockholder Consent by Inscobee Inc. and Apimeds, Inc. purporting to remove all Board members and executives on March 20, 2026, is invalid due to violation of an irrevocable proxy under the Support Agreement tied to the Merger Agreement with MindWave Innovations Inc. The Company will seek Delaware Court of Chancery validation that current directors Elona Kogan, Jakap Koo, Carol O’Donnell, Dr. Bennett Weintraub and executives Dr. Vin Menon and Mr. Erick Frim remain in office.
Event Type
Disclosure
Mandatory
Variant
8-K
. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 20
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Because the Stockholder Consent is invalid, the amendment to the Amended and Restated
. Other Events. MindWave Press Release On March 24, 2026, MindWave issued a press release (the “ MindWave Press Release ”) on behalf of the Company and with the
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by MindWave Innovations Inc. dated March 24, 2026. 104 Cover
Elona Kogan
Effective: N/A
Stockholder Consent invalid
Jakap Koo
Effective: N/A
Stockholder Consent invalid
Carol O’Donnell
Effective: N/A
Stockholder Consent invalid
Dr. Bennett Weintraub
Effective: N/A
Stockholder Consent invalid
Dr. Vin Menon
Effective: N/A
Stockholder Consent invalid
Mr. Erick Frim
Effective: N/A
Stockholder Consent invalid